Study reveals genetic variant linked to increased risk of leukemia in Hispanic/Latino children

Acute lymphoblastic leukemia (ALL), the most common childhood cancer, disproportionately affects children of Hispanic/Latino origin in the United States.

NSAIDs raise bleeding risk in patients taking blood thinners

People who take an anticoagulant medicine double their risk of an internal bleed if they take a type of painkiller called a non-steroidal anti-inflammatory drug

November 18, 2024

Heidelberg Pharma to Participate in Leading Scientific and Financial Conferences in November 2024 – Biotech Investments

EQS-News: Heidelberg Pharma AG / Key word(s): Conference Heidelberg Pharma to Participate in Leading Scientific and Financial Conferences in November 2024 24.10.2024 / 11:03 CET/CEST

October 25, 2024

Why Eli Lilly’s earnings didn’t quite live up to the hype

Eventually, the luckiest companies get to deal with a very particular problem: what to do when their stock could be getting ahead of itself. It’s

February 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.